Maria Sirenko is an Analyst at Catalio Capital Management, LP.
She is also a Ph.D. Candidate at Memorial Sloan Kettering Cancer Center. Her technical expertise is in the field of computational oncology. She uses integrated genomic techniques to study the impact of somatic mutations in high-risk Acute Myeloid Leukemia in the context of novel targeted inhibitors.
Maria earned a B.S. in Biological Engineering from Cornell University.